Prognosis in cutaneous T-cell lymphoma by skin stage: Long-term survival in 489 patients

Journal of the American Academy of Dermatology

Volumn 40, Issue 3, 1999, Pages 418-425

  Zackheim, H S ^a   Amin, S ^a   Kashani Sabet, M ^a   McMillan, A ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SKIN LYMPHOMA; T CELL LYMPHOMA;

EID: 0033007117     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(99)70491-3     Document Type: Article

References (19)

1. HK Koh M Charif MA Weinstock Epidemiology and clinical manifestations of cutaneous T-cell lymphoma Hematol Oncol Clin North Am 9 1995 943 960
2. SI Lamberg SB Green DP Byar JB Block WE Clendenning MC Douglass Clinical staging for cutaneous T-cell lymphoma Ann Intern Med 100 1984 187 192
3. EA Sausville JL Eddy RW Makuch AB Fischmann GP Schechter M Matthews Histopathologic staging at initial diagnosis of mycosis fungoides and the Sézary syndrome: definition of three distinctive prognostic groups Ann Intern Med 109 1988 372 382
4. YH Kim RA Jensen GL Watanabe A Varghese RT Hoppe Clinical stage IA (limited patch and plaque) mycosis fungoides Arch Dermatol 132 1996 1309 1313
5. JR Toro HL Stoll PC Stomper AR Oseroff Prognostic factors and evaluation of mycosis fungoides and Sézary syndrome J Am Acad Dermatol 37 1997 58 67
6. PE LeBoit TH McCalmont Cutaneous lymphomas and leukemias 8th ed D Elder R Elenitsas C Jaworsky Lever’s Histopathology of the skin 1997 : Lippincott-Raven Philadelphia 805 846
7. PJ Bunn SI Lamberg Report of the committee on staging and classification of cutaneous T-cell lymphoma Cancer Treat Rep 63 1979 725 728
8. AB Wallace The exposure treatment of burns Lancet 1 1951 501 504
9. CM Chan A Oreglia California life expectancy: abridged life table for California and Los Angeles County, 1989-91 1993 : Health and Welfare Agency, Department of Health Services Sacramento
10. SE Koch HS Zackheim ML Williams V Fletcher PL LeBoit Mycosis fungoides beginning in childhood and adolescence J Am Acad Dermatol 17 1987 563 570
11. MA Weinstock JF Reynes Validation of cause of death certification for outpatient cancers: the contrasting cases of melanoma and mycosis fungoides Am J Epidemiol 148 1998 1184 1186
12. HS Zackheim EH Epstein Jr WR Crain Topical carmustine (BCNU) for cutaneous T cell lymphoma: a 15-year experience in 143 patients J Am Acad Dermatol 22 1990 802 810
13. RM Marti T Estrach JC Reverter JM Mascaro Prognostic clinicopathologic factors in cutaneous T-cell lymphoma Arch Dermatol 127 1991 1511 1516
14. MA Weinstock JW Horm Mycosis fungoides in the United States: increasing incidence and descriptive epidemiology JAMA 260 1988 42 46
15. GP Haas WA Sakr Epidemiology of prostate cancer CA Cancer J Clin 47 1997 273 287
16. MA Swerlick S Chen The melanoma epidemic: Is increased surveillance the solution or the problem? Arch Dermatol 132 1996 881 884
17. PJ Lynch Lymphoma, leukemia, and related diseases 2nd ed WM Sams Jr PJ Lynch Principles and practice of dermatology 1996 Churchill Livingstone New York 308
18. HL Arnold Jr RB Odom WD James Andrews’ Diseases of the skin 1990 : WB Saunders Philadelphia 854
19. 389IL-2 fusion toxin in mycosis fungoides J Am Acad Dermatol 39 1998 63 73